Years of experience show that licensing is highly effective for ensuring that many more people in developing countries can access life-saving HIV medicines. CHAI and Access to Medicine Foundation have published a paper outlining best practice licensing models that originator companies should employ to enable widespread access to their drugs. It also explores how these companies can go beyond licensing to engage in broader supportive initiatives that help ensure their licenses have maximum impact.
